Abstract:BACKGROUND Hepatocellular carcinoma (HCC) is the third leading cause of death from malignant tumors worldwide. More than 50% of HCC cases occur in China. The prognosis remains poor and overall efficacy is still unsatisfactory. Chemotherapy resistance is the most important reason for the poor outcome. Much progress has been made in the study of chemotherapy resistance of HCC; however, the specific mechanisms of progression of HCC have still only been partially established. Therefore, the mechanism of chemotherapy resistance in HCC requires more research. AIM To investigate the effect of miR-34a expression on the growth inhibition of HepG2 cells by doxorubicin. METHODS A recombinant lentiviral vector containing miR-34a was constructed and transfected into HepG2 cells. The expression of miR-34a was detected by reverse transcription-polymerase chain reaction (commonly known as RT-PCR) before and after transfection. Cells were exposed to 2 μM doxorubicin or phosphate-buffered saline before and after transfection. Cell viability in each group was detected by MTT assay, and cell cycle and apoptosis were detected by flow cytometry. Changes in expression levels of phospho (p)-p53, sirtuin (SIRT) 1, cyclin D1, cyclin-dependent kinase (CDK) 4, CDK6, BCL-2, multidrug resistance protein (MDR) 1/P glycoprotein (P-gp), and AXL were detected by Western blotting. RESULTS Recombinant lentiviral vector LV-hsa-mir-34a was successfully constructed by restriction endonuclease digestion and sequencing. RT-PCR showed that expression of miR-34a in HepG2 cells was significantly upregulated after transfection (P < 0.01). MTT assay showed that growth of HepG2 cells was inhibited after upregulation of miR-34a, and viability was significantly decreased after combined treatment with doxorubicin (P < 0.01). Flow cytometry showed that the number of HepG2 cells in G1 phase increased, and G1 phase arrest was more obvious after intervention with doxorubicin (P < 0.01). The apoptosis rate of HepG2 cells was increased after upregulation of miR-34a, and became more obvious after intervention with doxorubicin (P < 0.01). Western blotting showed that upregulation of miR-34a combined with treatment with doxorubicin caused significant changes in the expression levels of p-p53, SIRT1, cyclin D1, CDK4, CDK6, BCL-2, MDR1/P-gp and AXL proteins (P < 0.01). CONCLUSION MiR-34a may enhance the inhibitory effect of doxorubicin by downregulating MDR1/P-gp and AXL, which may be related to p53 expression.

Effects of Small Interfering RNA Targeting Enhancer of Zeste Homolog 2 on Doxorubicin-Induced Cellular Senescence of Gastric Cancer Cell Line MKN28 Cells

[Effect of RAD18-siRNA on Proliferation and Chemotherapy Sensitivity of Human Esophageal Squamous Cell Carcinoma ECA-109 Cells].

Inhibition Enhancer of Zeste Homologue 2 Promotes Senescence and Apoptosis Induced by Doxorubicin in P53 Mutant Gastric Cancer Cells.

The effects of proliferation and apoptosis on gastric MKN-28 cells by silence EZH2

Inhibiting Enhancer of Zeste Homolog 2 Promotes Cellular Senescence in Gastric Cancer Cells SGC-7901 by Activation of P21 and P16

Doxorubicin-Induced Cancer Cell Senescence Shows a Time Delay Effect and is Inhibited by Epithelial-Mesenchymal Transition (EMT)

Ginsenoside Rh2 Ameliorates Doxorubicin-Induced Senescence Bystander Effect in Breast Carcinoma Cell MDA-MB-231 and Normal Epithelial Cell MCF-10A

Enhancer of Zeste Homolog 2 Depletion Induces Cellular Senescence Via Histone Demethylation along the Ink4/Arf Locus

Prevention of BMS-777607-induced Polyploidy/senescence by Mtor Inhibitor AZD8055 Sensitizes Breast Cancer Cells to Cytotoxic Chemotherapeutics.

MiR-34a Overexpression Enhances the Inhibitory Effect of Doxorubicin on HepG2 Cells

RNA-interfered survivin gene increases sensitivity of SKBr-3 cells to doxorubicin:an in vitro study

Influence of C-Erbb-2-sirna to the Radiosensitivity of Colon Cancer Cells

B7-H3 suppresses doxorubicin-induced senescence-like growth arrest in colorectal cancer through the AKT/TM4SF1/SIRT1 pathway

The effect of cell proliferation and migration by short hairpin RNA interference EZH2 expression in human lung cancer cell line

Enhanced Chemosensitivity by Simultaneously Inhibiting Cell Cycle Progression and Promoting Apoptosis of Drug-Resistant Osteosarcoma Mg63/Dxr Cells by Targeting Cyclin D1 and Bcl-2

An Epigenetic Mechanism Underlying Doxorubicin Induced EMT in the Human BGC-823 Gastric Cancer Cell.

[Effect of Small Interfering RNA Targeting Multidrug Resistance-Related Protein and Bcl-2 on Drug Resistance and Apoptosis of K562 and K562/ADM Cells].

[Effects of Enhancer of Zeste Homolog (EZH2) Downregulation on the Proliferation and Invasion of Nasopharyngeal Carcinoma Cell and the Possible Mechanisms].

Effects of down-regulating expression of X-linked inhibitor of apoptosis on chemotherapy induced apoptosis of gastric cancer cells

The Expression and Role of PTEN in Doxorubicin Induced Gastric Cancer Cell Apoptosis

Investigating the effect of LncRNA DLGAP1-AS2 suppression on chemosensitivity of gastric cancer to chemotherapy